These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7390575)

  • 21. On the relation between platelet monoamine oxidase activity and the growth hormone response in psychosis.
    Hitzemann R; Hirschowitz J; Zemlan F; Hitzemann B; Garver D
    Biol Psychiatry; 1983 Dec; 18(12):1503-7. PubMed ID: 6661478
    [No Abstract]   [Full Text] [Related]  

  • 22. Monoamines, monoamine oxidase and alcoholism.
    Sandler M
    Subst Alcohol Actions Misuse; 1983; 4(2-3):89-96. PubMed ID: 6139883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet monoamine oxidase activity in chronic schizophrenia.
    Trivedi JK; Tandon SK; Viswanathan PN; Gupta AK; Sethi BB
    Indian J Med Res; 1987 Jul; 86():79-83. PubMed ID: 3692563
    [No Abstract]   [Full Text] [Related]  

  • 24. Quantitative aspects on mitochondrial monoamine oxidase in human platelets.
    Wiberg A; Oreland L
    Med Biol; 1976 Apr; 54(2):137-41. PubMed ID: 1271873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet monoamine oxidase in schizophrenia with beta-phenylethylamine and benzylamine as substrates.
    Baron M; Perumal AS; Levitt M; Cannova G
    Biol Psychiatry; 1982 Apr; 17(4):479-83. PubMed ID: 7082713
    [No Abstract]   [Full Text] [Related]  

  • 26. Diminished activity of platelet monoamine oxidase in Down's syndrome.
    Benson PF; Southgate J
    Am J Hum Genet; 1971 Mar; 23(2):211-4. PubMed ID: 4253914
    [No Abstract]   [Full Text] [Related]  

  • 27. Platelet monoamine oxidase and the growth hormone response to apomorphine in schizophrenia.
    Malas KL; van Kammen DP; deFraites EA; Brown GM; Gold PW
    Biol Psychiatry; 1983 Feb; 18(2):255-9. PubMed ID: 6830934
    [No Abstract]   [Full Text] [Related]  

  • 28. Monoamine oxidase activity in blood platelets from autistic children.
    Takahashi S; Kanai H; Miyamoto Y
    Folia Psychiatr Neurol Jpn; 1977; 31(4):597-603. PubMed ID: 608661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurotransmitter systems and personality measurements: a study in psychosomatic patients and healthy subjects.
    Arqué JM; Unzeta M; Torrubia R
    Neuropsychobiology; 1988; 19(3):149-57. PubMed ID: 2904661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet monoamine oxidase activity in diabetics.
    Azevedo M; Fernandes F; Lisboa P; Manso C
    Acta Med Port; 1980; 2(5-6):369-76. PubMed ID: 7293813
    [No Abstract]   [Full Text] [Related]  

  • 31. Platelet monoamine oxidase (MAO) activity and genetic vulnerability to bipolar (BP) affective illness.
    Gershon ES; Targum SD; Leckman JF
    Psychopharmacol Bull; 1979 Jan; 15(1):27-30. PubMed ID: 419242
    [No Abstract]   [Full Text] [Related]  

  • 32. Platelet monoamine oxidase activity and headache: relationship to personality and smoking.
    Glover V; Littlewood JT; Sandler M; Peatfield R; Petty R; Rose FC
    Psychopharmacol Bull; 1984; 20(3):536-8. PubMed ID: 6473660
    [No Abstract]   [Full Text] [Related]  

  • 33. Platelet monoamine oxidase and serum dopamine-beta-hydroxylase activities in psychotic patients.
    Zizolfi S; Famiglietti LA; Del Vecchio M; Kemali D
    Acta Neurol (Napoli); 1979 Apr; 1(2):142-9. PubMed ID: 474224
    [No Abstract]   [Full Text] [Related]  

  • 34. Stability of low blood platelet monoamine oxidase activity in human alcoholics.
    Sullivan JL; Stanfield CN; Maltbie AA; Hammett E; Cavenar JO
    Biol Psychiatry; 1978 Jun; 13(3):391-7. PubMed ID: 667236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood platelet monoamine oxidase activity in psychiatric patients.
    Friedman E; Shopsin B; Sathananthan G; Gershon S
    Am J Psychiatry; 1974 Dec; 131(12):1392-4. PubMed ID: 4432940
    [No Abstract]   [Full Text] [Related]  

  • 36. Platelet monoamine oxidase activity in patients with chronic schizophrenic illnesses untreated by neuroleptic drugs [proceedings].
    Bailey AR; Crow TJ; Johnstone EC; Owen F
    Br J Clin Pharmacol; 1975 Aug; 2(4):380P. PubMed ID: 1234010
    [No Abstract]   [Full Text] [Related]  

  • 37. [Method of determining platelet monoamine oxidase activity].
    Voloshina ON; Moskvitina TA
    Lab Delo; 1985; (5):289-91. PubMed ID: 2409336
    [No Abstract]   [Full Text] [Related]  

  • 38. Platelet monoamine oxidase activity in neuroleptic-naive schizophrenic patients: lack of influence of chronic perphenazine treatment.
    Spivak B; Kosower N; Zipser Y; Shreiber-Schul N; Apter A; Tyano S; Weizman A
    Clin Neuropharmacol; 1994 Feb; 17(1):83-8. PubMed ID: 8149362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet monoamine oxidase activity and substrate preferences in schizophrenic patients.
    Meltzer HY; Stahl SM
    Res Commun Chem Pathol Pharmacol; 1974 Feb; 7(2):419-31. PubMed ID: 4594367
    [No Abstract]   [Full Text] [Related]  

  • 40. Human platelet monoamine oxidase activity and in vivo manipulation of plasma glucose concentration.
    Jackman HL; Meltzer HY
    Commun Psychopharmacol; 1980; 4(5):335-8. PubMed ID: 7333090
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.